23andMe to delist from Nasdaq, deregister with SEC
Furnished content.
Regeneron Pharmaceuticals said earlier this month that it will acquire "substantially all" of 23andMe's assets for $256 million.
Read more here
edit: Technology/auto___23andme_to_delist_from_nasdaq__deregister_with_sec.wikieditish...